-
Signature
-
/s/ Adam Levy, Attorney-in-fact
-
Stock symbol
-
MLYS
-
Transactions as of
-
May 12, 2025
-
Transactions value $
-
$6,857
-
Form type
-
4
-
Date filed
-
5/13/2025, 08:57 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rodman David Malcom |
Chief Medical Officer |
150 N. RADNOR CHESTER ROAD,, SUITE F200, RADNOR |
/s/ Adam Levy, Attorney-in-fact |
2025-05-13 |
0001672659 |
Transactions Table
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MLYS |
Stock Option |
Options Exercise |
$0 |
-6.35K |
-5.88% |
$0.00 |
102K |
May 12, 2025 |
Common Stock |
6.35K |
$1.08 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: